Disease Info Card

Exposure To Ionizing Radiation

Information about Exposure To Ionizing Radiation: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Exposure To Ionizing Radiation

Most recent studies have shown that Exposure To Ionizing Radiation shares some biological mechanisms with ataxia, ataxia-telangiectasia, carcinogenesis, carcinoma, cytogenetic-abnormality, genomic-instability, leukemia, leukemia-radiation-induced, malignant-neoplasm-of-breast, malignant-neoplasm-of-lung, malignant-neoplasm-of-thyroid, malignant-neoplasms, malignant-paraganglionic-neoplasm, mammary-neoplasms, neoplasms, neoplasms-radiation-induced, radiation-injuries-experimental, radiation-injury, telangiectasis, thyroid-neoplasm.

Among the many pathways, these few ones have gauged particular interests from scientists studying Exposure To Ionizing Radiation, and have been seen in publications frequently: Aging, Cell Cycle, Cell Cycle Arrest, Cell Cycle Checkpoint, Cell Death, Cell Growth, Cell Killing, Cell Proliferation, Dna Repair, Dna Replication, G2 Phase, Hypersensitivity, Localization, Metaphase, Mitosis, Pathogenesis, Response To Ionizing Radiation, Response To Radiation, S Phase, Transport

Quite a number of genes have been found to play important roles in Exposure To Ionizing Radiation, such as AKT1, ATM, BRCA1, CAT, CDKN1A, CHEK1, CHEK2, EGFR, NBN, NSG1, PAK3, PCNA, PRKDC, RAD51, TCEAL1, TNF, TP53, TP53BP1. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.